SCHEMBL25854502

SCHEMBL25854502

COC1CC2(C)C(CC3OC(C)(C)OC32C(=O)COC(C)=O)C2CC(C=O)=C3C=C(OCCCl)CCC3(C)C12F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 8/20 0.45
▸ NR3C1 P04150 7/20 0.45
▸ PGR P06401 7/20 0.45
▸ LMNA P02545 6/20 0.45
▸ AR P10275 4/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ CYP3A4 P08684 7/20 0.44
▸ USP2 O75604 2/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ CNR1 P21554 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ NR1I2 O75469 1/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21340498 0.93 HIF1A (0.43) HIF1ANR3C1PGRLMNAAR
Formocortal SCHEMBL4354 0.92 HIF1A (0.52) HIF1ANR3C1PGRLMNAAR
Formocortal SCHEMBL21234455 0.92 HIF1A (0.52) HIF1ANR3C1PGRLMNAAR
Formocortal SCHEMBL5484249 0.92 HIF1A (0.52) HIF1ANR3C1PGRLMNAAR
Formocortal SCHEMBL4353 0.92 HIF1A (0.52) HIF1ANR3C1PGRLMNAAR
SCHEMBL21340510 0.86 HIF1A (0.46) HIF1ANR3C1PGRLMNAAR
SCHEMBL6832364 0.83 CYP3A4 (0.54) HIF1ANR3C1PGRLMNAAR
SCHEMBL5034365 0.83 CYP3A4 (0.54) HIF1ANR3C1PGRLMNAAR
SCHEMBL21234457 0.83 CYP3A4 (0.50) HIF1ANR3C1PGRLMNAAR
Formocortal SCHEMBL6915676 0.82 HIF1A (0.43) HIF1ANR3C1PGRLMNAAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225975-A1 DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF RIPPLE THERAPEUTICS CORPORATION (CA) 2023-07-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230225975-A1 DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF NR3C1, NR3C2, CYP21A2 HIF1A 1543/4885NR3C1 1/4885PGR 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback